Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
31.01
+1.58 (5.37%)
Jan 22, 2026, 3:00 PM EST - Market open
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.66 billion as of January 22, 2026. Its market cap has increased by 101.30% in one year.
Market Cap
1.66B
Enterprise Value
1.38B
1-Year Change
101.30%
Ranking
Category
Stock Price
$31.01
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.66B, an increase of 152.82%. That is a compound annual growth rate of 23.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.57B | 11.94% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 1.67B |
| Kodiak Sciences | 1.66B |
| Corvus Pharmaceuticals | 1.65B |
| Intellia Therapeutics | 1.63B |
| Enliven Therapeutics | 1.61B |
| Novavax | 1.61B |
| Agios Pharmaceuticals | 1.58B |
| Precigen | 1.58B |